{"SPADE_UN_18942": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_18942", "Peptide Name": "cd3 (cyclic dimeric KR-12, synthetic AMPs, UCBB1)", "Source": "designed, human cathelicidin analog, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "AGKRIVQRIKDFLRGAGKRIVQRIKDFLRG", "Sequence Length": 30, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 3496.17, "PI": 12.0, "Hydrophobicity": -0.5, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Gunasekera S, Muhammad T, Strömstedt AA, Rosengren KJ, Göransson U.2020", "Reference": "Front Microbiol. 2020 Feb 21;11:168. doi: 10.3389/fmicb.2020.00168.PubMed", "Title": "Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability."}], "Frequent Amino Acids": "RGI", "Absent Amino Acids": "CEHMNOPSTUWY", "Basic Residues": 10, "Acidic Residues": 2, "Hydrophobic Residues": 12, "Polar Residues": 16, "Positive Residues": 10, "Negative Residues": 2, "Net Charge": 8, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (93.33%) tocd2K: 13%, R: 20%, I=G: 13%.Activity:  active against E. coli (MIC 5 uM), P. aeruginosa (MIC 10 uM), S. aureus (MIC 10 uM), and C. albicans (MIC 5 uM). Warning: Non-standard assay.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_00404", "Similarity": 1.0, "Sequence": "KRIVQRIKDFLR"}, {"SPADE_ID": "SPADE_UN_25884", "Similarity": 1.0, "Sequence": "KRIVQRIK"}, {"SPADE_ID": "SPADE_UN_25885", "Similarity": 1.0, "Sequence": "KRIVQRIK"}]}}}